Additional molecular protocols for codons in BRAF (“BRAF Codon 600 Mutation Detection by Pyrosequencing”), KRAS (“KRAS Mutation Detection”), and NRAS (“NRAS Mutation Detection by Pyrosequencing”) have been conceived by ARUP Laboratories (Salt Lake City, UT, USA) to help in the treatment of patients with different solid tumors, including melanoma. Here, KRAS is linked to melanoma.